-
Jan 31, 2023
-
Jan 31, 2023
-
AusDiagnostics is proud to announce its new partnership with OrthoDx, a leader in the orthopaedic surgical space.
Jan 30, 2023
-
Verisense® Health, Inc. launched today as a digital health software and data management company. It was established with the goal of providing sponsors with cost-efficient access to a digital biobank of longitudinal raw patient data. The new company is a spin-off from Dublin-based wearable technology services and sensor manufacturer Shimmer Research.
Jan 29, 2023
-
Jan 29, 2023
-
Jan 8, 2023
-
Jan 15, 2023
-
Jan 28, 2023
-
Jan 16, 2023
-
Jan 10, 2023
-
Announcement comes with the collaboration with biopharmaceutical industry to introduce colorectal cancer clinical trial
Jan 24, 2023
-
Recent accolades honoring the company’s technology and workplace reflect its growing industry impact
Jan 23, 2023
-
Transition to modern digital pathology will improve patient care and enable new research breakthroughs
Jan 17, 2023
-
FASTinov collaborates with Beckman Coulter Life Sciences to bring ultra-rapid 2h-AST disruptive technology to clinical microbiology laboratories
Jan 15, 2023
-
Jan 16, 2023
-
Jan 15, 2023
-
Isohelix has announced that it has commenced engagement with the U.S. Food and Drug Administration to progress the full regulatory approval of the GeneFix® Saliva DNA Collectors into the USA.
Jan 10, 2023
-
Investment will support ongoing partnerships with apheresis clinics, expansion of laboratory services, enhancement of patient data aggregation, and amplification of Sanguine’s network of 60,000+ research-ready patient donor network.
Jan 8, 2023
-
Precision BioLogic Inc., a leading developer of hemostasis diagnostic products, is pleased to announce FDA 510(k) clearance and the launch of its new CRYOcheck™ Chromogenic Factor IX assay in the U.S.
The latest in Precision BioLogic’s family of hemophilia-related diagnostic products, CRYOcheck Chromogenic Factor IX is intended for use by clinical labs to identify factor IX (FIX) deficiency in human plasma and aid in the management of hemophilia B. It is the only FDA-cleared chromogenic FIX assay on the market and answers a growing demand for such tests.
Jan 4, 2023
-
CD BioSciences has recently announced the launch of label-free live cell imaging services for scientific studies.
Jan 4, 2023